O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study
Saved in:
Main Authors: | J. Grebely (Author), O. Dalgard (Author), B. Conway (Author), E. Cunningham (Author), P. Bruggmann (Author), B. Hajarizadeh (Author), J. Amin (Author), P. Marks (Author), S. Quiene (Author), T.L. Applegate (Author), T. Swan (Author), J. Byrne (Author), M. Lacalamita (Author), A. Dunlop (Author), J. Bruneau (Author), M.E. Hellard (Author), G.V. Matthews (Author), J. Powis (Author), D. Shaw (Author), M.C. Thurnheer (Author), M. Weltman (Author), I. Kronborg (Author), C. Cooper (Author), J.J. Feld (Author), C. Fraser (Author), A. Litwin (Author), J. Dillon (Author), P. Read (Author), E. Gane (Author), G.J. Dore (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
by: Mir F, et al.
Published: (2017) -
Eight-week treatment with sofosbuvir/velpatasvir may be effective in curing hepatitis C in children
by: Maria Pokorska-Śpiewak, et al.
Published: (2024) -
Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence
by: Brigham D, et al.
Published: (2024) -
Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan
by: Saima Mushtaq, et al.
Published: (2020) -
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection
by: Pajaree Chariyavilaskul, et al.
Published: (2024)